These industry platform meetings complement those organised by EMA's Industry Standing Group and annual bilateral meetings with industry associations representing specific sectors.
Both the Industry Standing Group meetings and annual bilateral meetings focus on exchange of views, although the latter take a high level approach while the former also look to facilitate the implementation of new legislative proposals.
Fore more information, see:
Nominated experts from EU trades attend the industry platform meetings.
Use the links included in the sections below to view meeting agendas, summaries and any related presentations made available.
These meetings address evidence generation during the life-cycle of medicines.
They also focus on development support activities such as scientific advice and qualification, as well as on paediatric and orphan medicines.
These meetings aim to provide an opportunity to discuss specific processes or issues to support continuous improvement and foster dialogue with pharmaceutical industry stakeholders.
They provide updates on current operations, achievements and planned improvements.
Participants focus on interactions with applicants during evaluation procedures and on the management of variations.
These meetings aim to raise awareness of pharmacovigilance legislation requirements, promote dialogue and provide an opportunity for discussions on specific issues affecting the Agency's industry partners.